Post-approval studies (Phase 4)Ended earlyNCT00972543What this trial is testingRaptiva in Palm and Sole PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Ended earlyNCT00739882What this trial is testingTRUST Study: Raptiva ® in Hand & Foot PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 76
Early research (Phase 1)Ended earlyNCT03310320What this trial is testingStudy to Determine if AZD0284 is Effective and Safe in Treating Plaque PsoriasisWho this might be right forPlaque Psoriasis Vulgaris AstraZeneca 9
Testing effectiveness (Phase 2)Study completedNCT05531682What this trial is testingEvaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Huabo Biopharm Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01519089What this trial is testingA Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisWho this might be right forPsoriasis Pfizer 95
Testing effectiveness (Phase 2)Study completedNCT04572997What this trial is testingApremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)Who this might be right forPalmoplantar Pustulosis Kristian Reich 21
Large-scale testing (Phase 3)Study completedNCT00674063What this trial is testingAssess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 78
Not applicableLooking for participantsNCT06792487What this trial is testingImmune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)Who this might be right forPsoriasis Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Large-scale testing (Phase 3)Study completedNCT03370133What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis UCB Biopharma SRL 567
Large-scale testing (Phase 3)Study completedNCT02346240What this trial is testingEfficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)Who this might be right forPsoriasisPlaque Psoriasis UCB Biopharma S.P.R.L. 559
Large-scale testing (Phase 3)Study completedNCT00574249What this trial is testingAdalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic TreatmentWho this might be right forChronic Plaque Psoriasis Abbott 730
Not applicableNot Yet RecruitingNCT06811558What this trial is testingIxekizumab Versus Secukizumab in Over 70-year-old Patients with PsoriasisWho this might be right forOver 70-year-old Patients with Psoriasis Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT05223868What this trial is testingJNJ-77242113 in Participants With Moderate-to-severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Janssen Research & Development, LLC 255
Early research (Phase 1)Study completedNCT01094093What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis AstraZeneca 73
Early research (Phase 1)Study completedNCT05728489What this trial is testingTest How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 64
Large-scale testing (Phase 3)Study completedNCT01358578What this trial is testingSafety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 1,306
Post-approval studies (Phase 4)Study completedNCT01356004What this trial is testingEffective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant PsoriasisWho this might be right forPsoriasis Cairo University 35
Post-approval studies (Phase 4)Study completedNCT00663052What this trial is testingStudy Evaluating Etanercept for the Treatment of Moderate to Severe PsoriasisWho this might be right forPlaque PsoriasisPsoriasis Pfizer 273
Large-scale testing (Phase 3)Study completedNCT03412747What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Plaque Psoriasis UCB Biopharma SRL 478
Post-approval studies (Phase 4)Active Not RecruitingNCT03240809What this trial is testingAn Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric SubjectsWho this might be right forPsoriasis Bausch Health Americas, Inc. 2